Comparison of two drugs for assessing the easier insertion conditions of a airway device to give General Anaesthesia

Comparison of Butorphanol and Dexmedetomidine as adjuvants to Propofol for ease of Baska Mask insertion for short procedures Ã¢â?¬â?? A Prospective Double blind Randomized controlled study.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022209

Enrollment

Registered

2019-12-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group A Propofol 2.5 mg/kg and Dexmedetomidine 0.5Ã?Âµ/kg diluted in 20 ml Saline and given over infusion for 10 mins: Patients will be pre oxygenated for 3 minutes, with 100% oxygen fo

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to our hospital posted for short surgical procedures coming under American Society of Anaesthesiologists grade I or II. Mallampati Grade I & II Surgeries lasting for 1 to 2 hours (like short gynaecologic procedures, Incision and drainage and fibroadenoma excision)

Exclusion criteria

Exclusion criteria: Emergency surgeries Patients at the risk of aspiration (hiatus hernia, pregnancy, full stomach, intestinal ileus) Patients with known gastrointestinal reflux, sore throat, upper respiratory airway infections. Patients suffering from pharyngeal pathology e.g. abscess, haematoma and tissue disruption. Low pulmonary compliance e.g. morbid obesity, bronchospasm or pulmonary oedema. Patients undergoing oral surgery and those allergic to propofol, Dexmedetomidine or Butorphanol.

Design outcomes

Primary

Measure	Time frame
To compare Butorphanol and Dexmedetomidine as adjuvants to propofol on the insertion conditions of Baska Mask for short proceduresTimepoint: 2 hours	—

Secondary

Measure	Time frame
1. The ease of insertion (assessed by the duration of time taken to insert them successfully and the number of insertion attempts)Timepoint: 1 hour ;2. To assess the incidence of complications such as laryngospasm during insertionTimepoint: 2 hours;3. To detect the hemodynamic responses induced by airway insertion (blood pressure, heart rate, oxygen saturation and end-tidal carbon dioxide (EtCO2)Timepoint: 2 hours	—

Measure

Time frame

1. The ease of insertion (assessed by the duration of time taken to insert them successfully and the number of insertion attempts)Timepoint: 1 hour ;2. To assess the incidence of complications such as laryngospasm during insertionTimepoint: 2 hours;3. To detect the hemodynamic responses induced by airway insertion (blood pressure, heart rate, oxygen saturation and end-tidal carbon dioxide (EtCO2)Timepoint: 2 hours

—

Countries

India

Contacts

Public ContactDr Ranjan R V

Pondicherry Institute of Medical Sciences

ranjanrv2005@gmail.com9600823772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026